Fosamax Lawsuit

More Fosamax lawsuit Information

If you or a family member have taken Fosamax and been diagnosed with osteonecrosis of the jaw or experienced symptoms of jaw death, you should seek a free consultation regarding your legal rights.  Fosamax lawyer is currently investigating Fosamax lawsuit claims against the drug manufacturer for failing to warn patients and dentists of the known side effects of Fosamax jaw necrosis.  You and your family may be entitled to compensation for this painful condition which could have been prevented.

Osteonecrosis

Fosamax lawsuit Evidence has also revealed that Fosamax can increase the risk of osteonecrosis, a serious bone disease of the jaw (ONJ). According to experts in the field, ONJ is a condition in which the bone tissue in the jaw fails to heal after minor trauma such as a tooth extraction, causing the bone to be exposed. This exposure can lead to infection, fracture, and extensive tissue death, requiring long-term antibiotic use or surgery to correct.

One study, quoted by United Press International in April 2006, found that nearly 2,500 patients taking a bisphosphonate like Fosamax, have suffered jaw-bone damage since 2001. Another 120 patients suffered incapacitating bone, muscle, or joint pain. Health experts have discovered 1,100 cases of Fosamax osteonecrosis in the past six to nine months. nuvaring lawyer

Nuva lawsuit  , nuvaring side effects

-Nuvaring lawsuit   nuvaring side effects

Fosamax lawsuit Firm

Fosamax ® Information

Fosamax ® (generic name - Alendronate) is a type of drug known as bisphosphonates. Recently a link has been found between bisphosphonates and a serious bone disease called osteonecrosis of the jaw (ONJ). This important discovery clearly shows that Fosamax ® side effects may include osteonecrosis of the jaw.

The discovery, published in the Journal of Oral and Maxillofacial Surgeons, prompted both the US, Food and Drug Administration (FDA) and Novartis, the manufacturer of bisphosphonates used in cancer chemotherapy, to issue a warning to health care professionals on September 24, 2004. The warning letter contained information about bisphosphonates and the risks of osteonecrosis in the jaw.

Bisphosphonates are commonly used in tablet form such as Fosamax ® (Alendronate Sodium) to prevent and treat osteoporosis in post-menopausal women. Stronger forms of bisphosphonates are commonly used in the management of advanced cancers that have metastasized to the bone, where the disease often causes bone pain and possibly even fractures. Several cancers can involve or metastasize to the bone, including lung cancer, breast cancer, prostate cancer, multiple myeloma, and others. When bisphosphonates are given in cancer chemotherapy, the drugs are given intravenously, and usually for longer periods of time.